ONE-YEAR TREATMENT WITH FENOFIBRATE (PROCETOFEN) OF PATIENTS AFFECTED BY PRIMARY TYPE-II HYPERLIPOPROTEINEMIA - EFFECT ON LIPOPROTEIN LIPIDS AND BIOCHEMICAL TOLERANCE

被引：0
|
作者：
DROUIN, P
MEJEAN, L
LAMBERT, D
WULFERT, E
DEBRY, G
机构：
[1] INSERM, U59, RECH NUTR GRP, F-54000 NANCY, FRANCE
[2] LABS FOURNIER DIJON, CTR RECH, F-21300 CHENOVE, FRANCE
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1980年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：728 / 734
页数：7
相关论文
共 24 条
  • [1] EFFECT OF FENOFIBRATE (PROCETOFEN) ON THE LIPOPROTEIN PROFILE IN PATIENTS AFFECTED BY PRIMARY TYPE-II HYPERLIPOPROTEINEMIA
    DROUIN, P
    MEJEAN, L
    LAMBERT, D
    SAUVANET, JP
    DEBRY, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 26 (03): : 350 - 356
  • [2] IMPACT OF PROCETOFEN ON THE LIPOPROTEIN PROFILE IN PATIENTS WITH PRIMARY HYPERLIPOPROTEINEMIA TYPE-II
    DROUIN, P
    MEJEAN, L
    LAMBERT, D
    SAUVANET, JP
    DEBRY, G
    MEDIZINISCHE WELT, 1979, 30 (50): : 1910 - 1913
  • [3] EFFECT OF COLESTIPOL ON PLASMA-LIPIDS IN PATIENTS AFFECTED BY TYPE-II PRIMARY HYPERLIPOPROTEINEMIA
    DROUIN, P
    SAUVANET, JP
    LAMBERT, D
    MEJEAN, L
    DEBRY, G
    THERAPIE, 1980, 35 (04): : 457 - 464
  • [4] ONE YEAR FENOFIBRATE TREATMENT OF TYPE-II PRIMARY HYPERLIPEMIA - EFFECTS ON LIPOPROTEINS AND BIOLOGICAL TOLERANCE
    DROUIN, P
    MEJEAN, L
    LAMBERT, D
    WULFERT, E
    DEBRY, G
    NOUVELLE PRESSE MEDICALE, 1980, 9 (49): : 3753 - 3757
  • [5] HYPOLIPIDEMIC EFFECT OF CHOLESTYRAMINE IN PATIENTS AFFECTED BY TYPE-II HYPERLIPOPROTEINEMIA
    SAUVANET, JP
    DROUIN, P
    MEJEAN, L
    LAMBERT, D
    DEBRY, G
    THERAPIE, 1978, 33 (05): : 615 - 622
  • [6] EFFECT OF CHOLESTYRAMINE ON LIPOPROTEIN LIPIDS IN PATIENTS WITH PRIMARY TYPE-IIA HYPERLIPOPROTEINEMIA
    WEISWEILER, P
    NEUREUTHER, G
    SCHWANDT, P
    ATHEROSCLEROSIS, 1979, 33 (03) : 295 - 300
  • [7] EFFECT OF GLUCOMANNAN ON PLASMA-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH TYPE-II HYPERLIPOPROTEINEMIA
    HUNNINGHAKE, DB
    PETERS, JR
    KUBA, K
    FRANTZ, ID
    CIRCULATION, 1984, 70 (04) : 289 - 289
  • [8] ONE-YEAR STUDY OF THE EFFECT OF POLICOSANOL ON LIPID PROFILE IN PATIENTS WITH TYPE-II HYPERCHOLESTEROLEMIA
    CANETTI, M
    MOREIRA, M
    ILLNAIT, J
    MAS, R
    FERNANDEZ, L
    FERNANDEZ, JC
    CASTANO, G
    ADVANCES IN THERAPY, 1995, 12 (04) : 245 - 254
  • [9] EFFECT OF ACIPIMOX AND PANTETHINE ON SERUM-LIPIDS AND APOPROTEINS IN PATIENTS WITH TYPE-II HYPERLIPOPROTEINEMIA
    CAPURSO, A
    RESTA, F
    CIANCIA, D
    LAVEZZARI, M
    MOGAVERO, AM
    TAVERNITI, R
    DITOMMASO, M
    SICILIANI, G
    PALMISANO, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 42 (06): : 1216 - 1222
  • [10] LONG-TERM EFFECTS OF FENOFIBRATE ON SERUM-LIPIDS AND ON LIPOPROTEIN CHOLESTEROL IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SOMMARIVA, D
    BONFIGLIOLI, D
    POGLIAGHI, I
    CABRINI, E
    FASOLI, A
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1984, 16 (08): : 809 - 820
123